Parra, G. A., Lindarte, H. H., & Rubio, A. F. (2020). Over optimum response to PCSK-9 inhibitors: ¿is it mandatory to supply them every 2 weeks?, about a case. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 7(1), 43–44. https://doi.org/10.53853/encr.7.1.568